| Product Code: ETC406865 | Publication Date: Oct 2022 | Updated Date: Jul 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The United Kingdom (UK) Animal Model Market was estimated at USD 478 Million in 2025 and is projected to reach USD 591 Million by 2032, growing at a CAGR of 3.1% from 2026 to 2032. This growth is primarily driven by robust investments in research and development across pharmaceuticals and biotechnology, alongside an increasing emphasis on advanced disease modeling techniques. Furthermore, the burgeoning focus on personalized medicine continues to enhance demand for specialized animal models, indicating a promising trajectory for the market.
This graph highlights how the United Kingdom (UK) Animal Model Market has steadily grown over the years, supported by major growth factors.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate | Major Drivers |
| 2021 | 3.7% | Rising investments in biotechnology research |
| 2022 | -2.1% | weak international trade demand |
| 2023 | 4.5% | Increased funding for medical research |
| 2024 | 5.6% | Growth in pharmaceutical development projects |
| 2025 | 4.3% | Expansion of regulatory compliance requirements |
| 2026 | 2.3% | Surge in academic research collaborations |
| 2027 | 2.4% | Growing focus on personalized medicine |
| 2028 | 4.6% | Heightened demand for preclinical studies |
| 2029 | 4.7% | Advancements in research technologies integration |
| 2030 | 4.8% | Rise in government research funding |
| 2031 | 4.6% | Increase in global research partnerships |
| 2032 | 4.0% | Emergence of new therapeutic areas |
Note: Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary forecasting methodology, utilizing the latest available industry data, government publications, and primary research inputs.
A key force shaping the UK Animal Model Market is the significant investment in innovative research methodologies, particularly concerning personalized and regenerative medicine. The country's advanced research infrastructure and skilled workforce are pivotal in fostering collaboration among various stakeholders, including academic institutions and pharmaceutical companies.
Moreover, ethical considerations surrounding animal welfare are leading to a transformative approach within the market. This has prompted the development of more humane and sophisticated animal models, aligning research practices with modern ethical standards, thereby positioning the UK as a leader in responsible research.
Despite the favorable growth landscape, the UK Animal Model Market faces notable restraints, primarily centered around ethical concerns regarding animal testing. Advocacy from various public groups increases scrutiny on research methodologies, pushing for alternative solutions. Compliance with stringent regulatory frameworks, including the Animals (Scientific Procedures) Act, complicates the approval processes for studies utilizing animal models. Consequently, stakeholders must navigate a challenging environment that balances innovation with ethical responsibilities.
The market is currently witnessing a surge in demand for genetically modified animal models, particularly as researchers delve deeper into the complexities of diseases and treatments. With advancements in technologies such as CRISPR/Cas9 gene editing, the precision of creating customized animal models has increased significantly, enabling targeted studies in drug discovery. Additionally, there is a growing emphasis on animal welfare, prompting the development of models that adhere to enhanced humane standards while still yielding valuable research outcomes.
Investors seeking entry into the UK Animal Model Market will find promising opportunities in the burgeoning fields of personalized medicine and regenerative therapies. The demand for animal models that closely replicate human diseases signals a growing market for companies specializing in genetically modified organisms. There is also potential in non-pharmaceutical sectors, such as agricultural research and environmental studies, indicating broad horizons for investment and growth in the animal model supply chain.
The UK government has established a comprehensive regulatory framework to oversee the use of animals in research, primarily governed by the Animals (Scientific Procedures) Act 1986. This legislation mandates that all animal research must be ethically justified and adhere to rigorous welfare standards. The Home Office plays a crucial role in licensing research entities, promoting compliance, and ensuring that ethical principles are upheld. Additionally, initiatives by the National Centre for the Replacement, Refinement, and Reduction of Animals in Research (NC3Rs) focus on developing alternative methods to decrease reliance on animal models, fostering innovation while maintaining high ethical standards.
Looking ahead to 2026-2032, the UK Animal Model Market is expected to witness steady growth, propelled by advancements in biopharmaceutical research and development. The rising complexity of disease mechanisms will necessitate more sophisticated animal models, particularly as personalized medicine takes center stage. The regulatory landscape will continue to evolve, supporting ethical research practices while encouraging innovation. As technological breakthroughs emerge, such as humanized models that offer deeper insights into human biology, the market stands poised for sustained expansion, promising a dynamic future.
Recent months have seen a shift towards innovative methodologies within the UK Animal Model Market, with researchers increasingly embracing advanced genetic technologies. Studies indicate a rise in collaborations between academic institutions and industry players to enhance the quality and relevance of animal models for various applications. Furthermore, public discourse on ethical animal research continues to shape the regulatory framework, emphasizing the need for transparency and responsible practices within the sector. These trends indicate a robust commitment to balancing scientific advancement with ethical standards.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Animal Model Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Animal Model Market Revenues & Volume, 2022 & 2032F |
3.3 United Kingdom (UK) Animal Model Market - Industry Life Cycle |
3.4 United Kingdom (UK) Animal Model Market - Porter's Five Forces |
3.5 United Kingdom (UK) Animal Model Market Revenues & Volume Share, By Animal Type , 2022 & 2032F |
3.6 United Kingdom (UK) Animal Model Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.7 United Kingdom (UK) Animal Model Market Revenues & Volume Share, By End Users, 2022 & 2032F |
4 United Kingdom (UK) Animal Model Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increased focus on research and development activities in the pharmaceutical and biotechnology industries |
4.2.2 Rising demand for personalized medicine and precision therapies |
4.2.3 Growing prevalence of chronic diseases necessitating animal models for research purposes |
4.3 Market Restraints |
4.3.1 Ethical concerns and regulatory restrictions related to the use of animals in research |
4.3.2 Availability of alternative technologies such as in vitro models and computational modeling |
4.3.3 High costs associated with the maintenance and use of animal models in research |
5 United Kingdom (UK) Animal Model Market Trends |
6 United Kingdom (UK) Animal Model Market, By Types |
6.1 United Kingdom (UK) Animal Model Market, By Animal Type |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Animal Model Market Revenues & Volume, By Animal Type , 2022-2032F |
6.1.3 United Kingdom (UK) Animal Model Market Revenues & Volume, By Rat, 2022-2032F |
6.1.4 United Kingdom (UK) Animal Model Market Revenues & Volume, By Mice, 2022-2032F |
6.1.5 United Kingdom (UK) Animal Model Market Revenues & Volume, By Guinea Pigs, 2022-2032F |
6.1.6 United Kingdom (UK) Animal Model Market Revenues & Volume, By Rabbits, 2022-2032F |
6.1.7 United Kingdom (UK) Animal Model Market Revenues & Volume, By Others, 2022-2032F |
6.2 United Kingdom (UK) Animal Model Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Animal Model Market Revenues & Volume, By Drug Discovery & Development, 2022-2032F |
6.2.3 United Kingdom (UK) Animal Model Market Revenues & Volume, By Basic Research, 2022-2032F |
6.2.4 United Kingdom (UK) Animal Model Market Revenues & Volume, By Others, 2022-2032F |
6.3 United Kingdom (UK) Animal Model Market, By End Users |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Animal Model Market Revenues & Volume, By Pharma & Biotech Companies, 2022-2032F |
6.3.3 United Kingdom (UK) Animal Model Market Revenues & Volume, By Academic Research Institutes, 2022-2032F |
6.3.4 United Kingdom (UK) Animal Model Market Revenues & Volume, By Others, 2022-2032F |
7 United Kingdom (UK) Animal Model Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Animal Model Market Export to Major Countries |
7.2 United Kingdom (UK) Animal Model Market Imports from Major Countries |
8 United Kingdom (UK) Animal Model Market Key Performance Indicators |
8.1 Number of new drug approvals based on research using animal models |
8.2 Investments in research and development in the pharmaceutical and biotechnology sectors |
8.3 Number of collaborations between research institutions and companies for animal model research |
9 United Kingdom (UK) Animal Model Market - Opportunity Assessment |
9.1 United Kingdom (UK) Animal Model Market Opportunity Assessment, By Animal Type , 2022 & 2032F |
9.2 United Kingdom (UK) Animal Model Market Opportunity Assessment, By Application, 2022 & 2032F |
9.3 United Kingdom (UK) Animal Model Market Opportunity Assessment, By End Users, 2022 & 2032F |
10 United Kingdom (UK) Animal Model Market - Competitive Landscape |
10.1 United Kingdom (UK) Animal Model Market Revenue Share, By Companies, 2025 |
10.2 United Kingdom (UK) Animal Model Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here